Pass Our Capabilities- Pages Big-2.png

Lowering development costs


Pass Our Capabilities Pages Small-2.png

We’re taking a scalpel to biologic development costs by using advanced analytics to demonstrate analytical resemblance between biosimilars candidates and reference biologics.

It’s an innovative approach we’re using to reduce the scope and cost of human clinical trials – which can significantly
lower the cost of drug development.


Teva biosimilars Mission: Making Biosimilars accessible to patients who need them

Our mission

Learn how we're making biosimilars more accessible.

Learn more
Teva Capabilities: Finding new ways to unleash value

Our capabilities

See how we’re unleashing value on many fronts.

Learn more
Teva Biosimilar Expertise: Meet the Leaders of Teva

Our expertise

Meet the vanguards leading the way in the new frontier.

Learn more
Teva Biosimilar Products and Partnerships

Our biosimilars

Discover our innovations in the new frontier.

Learn more
Exploring Biosimilars with Teva Biosimilars

Explore biosimilars

Learn why biosimilars are the new frontier.

Learn more